2024. Health-Related Quality of Life in Patients with Metastatic Basal Cell Carcinoma Treated with Cemiplimab: Analysis of a Phase 2 Open-Label Clinical Trial. SKIN The Journal of Cutaneous Medicine. 8, 1 (Jan. 2024), s337. DOI:https://doi.org/10.25251/skin.8.supp.337.